제휴제안

CONTACT US [개인정보처리방침]
RESEARCH

연구개발

네오젠TC의 연구 및 성과를 확인해보세요.

파이프라인

Platform Project Theraqeutics Indication R&D Preclinical Phase I Phase II NDA
TIL NEOG-100 TIL Solid tumor (TNBC, NSCLC)
TIL NEOG-200 TIL-LAK Solid tumor
TIL NEOG-300 NeoAg-TIL Solid tumor
TCR-T NEOG-400 Private NeoAg-TCR-T Solid tumor
  • NEOG-100

    • Theraqeutics

      TIL
    • Indication

      Solid tumor (TNBC, NSCLC)
    • R&D
    • Preclinical
    • Phase I
    • Phase II
    • NDA
  • NEOG-200

    • Theraqeutics

      TIL-LAK
    • Indication

      Solid tumor
    • R&D
    • Preclinical
    • Phase I
    • Phase II
    • NDA
  • NEOG-300

    • Theraqeutics

      NeoAg-TIL
    • Indication

      Solid tumor
    • R&D
    • Preclinical
    • Phase I
    • Phase II
    • NDA
  • NEOG-400

    • Theraqeutics

      Private NeoAg-TCR-T
    • Indication

      Solid tumor
    • R&D
    • Preclinical
    • Phase I
    • Phase II
    • NDA